Psychopathology in male and female intravenous drug users with and without HIV infection.

HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, New York.
American Journal of Psychiatry (Impact Factor: 13.56). 12/1994; 151(11):1662-8.
Source: PubMed

ABSTRACT The authors report on results of systematic clinical assessment of psychopathology among HIV-positive and HIV-negative intravenous drug users.
As part of a multidisciplinary baseline assessment, 147 male (85 HIV-positive and 62 HIV-negative) and 76 female (39 HIV-positive and 37 HIV-negative) intravenous drug users were evaluated with the Structural Clinical Interview for DSM-III-R and measures of psychiatric symptom severity, global functioning, and stress.
Prevalence of a diagnosis of current depression (26%) and severity of depressive and anxiety symptoms in both HIV-positive and HIV-negative subjects were greater than in the general community, but not greater than in other studies of intravenous drug users. HIV-positive men had a higher prevalence of depressive disorders than HIV-negative men (33% and 16%, respectively), although this pattern was not found among women (26% and 30%). Diagnosis of depressive disorders and severity of depressive and anxiety symptoms were associated with a symptom-based measure of HIV illness stage, but not with indices of immune functioning (CD4+ cell count and CD4+ cell percent).
Despite selective associations between HIV illness variables and depression, high rates of depression across HIV status in this cohort suggest that intravenous drug use and associated factors are more salient than HIV illness factors in understanding psychopathology in this population.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Psychiatric morbidity in human immunodeficiency virus (HIV) patients is being studied all over the world. There is paucity of Indian literature particularly in asymptomatic HIV individuals.
    Industrial psychiatry journal 07/2013; 22(2):125-30.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Prevalence studies consistently show that most people with HIV illness do not have elevated rates of psychiatric disorder at any given time, but these studies do not permit characterization of overall levels of psychological distress in this population. This paper reviews published studies examining distress and depressive symptomatology in people with HIV/AIDS and matched comparison groups as assessed by self-report rating scales. Findings indicate that distress levels differ considerably across studies in comparison to population norms, although scores typically are not highly elevated for either seropositive or seronegative groups. Methodological issues that may explain variation across studies are discussed, including recruitment methods, composition of samples, and methods of assessing distress. It is suggested that psychological distress in those with HIV/AIDS should be examined with an understanding of the diversity of factors that can contribute to distress, as well as the differential availability of resources to cope with stressors among those infected.
    AIDS and Behavior 01/1997; 01(1). · 3.49 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mental health and HIV are closely interlinked. A number of previous studies attempted primarily in the western countries have found a robust link between HIV/AIDS and psychiatric illness, including increased suicidal risk. The current study attempts to examine the relationship between HIV infection and the presence of a psychiatric illness, especially suicidal risk in the same sample population. 129 HIV positive cases along with 50 demographically similar controls participated in the study. All samples underwent detailed psychiatric assessment using ICD-10 criteria and further subjected to SCAN (Schedule for clinical assessment in neuropsychiatry) and BSS (Beck's scale for suicidal ideation). The HIV positive cases were found to be having significantly higher rates of psychiatric diagnosis (n=66,51%) as well as almost three times increased suicidal risk as compared to HIV negative controls. The findings highlight the susceptibility of HIV patients to having a psychiatric illness as well as an increased suicidal risk.